General Surgery
Krysta M. Sutyak, DO
Resident
University of Nebraska Medical Center
University of Nebraska Medical Center
Disclosure(s): No financial relationships to disclose
Surgical stabilization of rib fractures (SSRF) is an emerging therapy for the treatment of patients with traumatic rib fractures. Despite the demonstrated benefits of SSRF, there remains a paucity of literature regarding the complications from SSRF, especially those related to hardware infection. Currently, literature quotes hardware infection rates as high as 4%. We hypothesize that the hardware infection rate is much lower than currently published.
Methods or Case Description: This is an IRB approved, four-year multicenter descriptive review of prospectively collected data from January 2016 - January 2020. All patients undergoing SSRF were included in the study. Exclusion criteria included those patients < 18 years of age. Basic demographics were obtained: age, gender, Injury Severity Score (ISS), Abbreviate Injury Scale-chest (AIS-chest), flail chest (yes/no), delayed SSRF > 2 weeks (yes/no) and number of ribs fixated. Primary outcome was hardware infection. Secondary outcomes included mortality rate and hospital length of stay (HLOS). Basic descriptive statistics were utilized for analysis.
Outcomes:
A total of 238 patients met criteria for inclusion in the study. Mean age was 58 ± 15.2 years and 70% were male. Mean ISS was 17.3 ± 8.5 with a mean AIS-chest of 3.2 ± 0.5. Flail chest (two consecutive ribs with two or more fractures on each rib) accounted for 32% of patients. 26 patients (10.9%) underwent delayed SSRF. The average number of ribs stabilized was 4 ± 2.8. When analyzing the primary outcome, only 1 patient (0.4%) developed a hardware infection requiring reoperation to remove the plates. This patient was a delayed SSRF. Zero patients in the acute setting developed a hardware infection. Overall HLOS was 10.5 ± 6.8 days. Three patients suffered a mortality (1.3%), all three with ISS scores higher than 15 suggesting significant polytrauma.
Conclusion:
This is the largest case series to date examining SSRF hardware infection. The incidence of SSRF hardware infection is very low ( < 0.5%), much less than quoted in current literature. Furthermore, in this study, no patient developed hardware infection when the SSRF was completed within two weeks of injury. This is likely due to advances in the surgical technique through muscle-sparing incisions and minimally invasive SSRF. Overall, SSRF is a safe procedure with low morbidity and mortality.